A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Hepato Cellular Carcinoma (HCC)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Peng Wang, MD) · peng_wang@fudan.edu.cn · 8621-64041990
Contact: Principal Investigator (Peng Wang, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab

Hepato Cellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE2

Bologna, Italy

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Hepato Cellular Carcinoma (HCC) · Hand Foot Skin Syndrome

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma

Hepato Cellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

IIT2025-03-YANG-LIFT-HCC

Hepato Cellular Carcinoma

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States